Search

Your search keyword '"Ghadimi, Michael"' showing total 829 results

Search Constraints

Start Over You searched for: Author "Ghadimi, Michael" Remove constraint Author: "Ghadimi, Michael"
Sorry, I don't understand your search. ×
829 results on '"Ghadimi, Michael"'

Search Results

3. Transatlantic differences in the use and outcome of minimally invasive pancreatoduodenectomy: an international multi-registry analysis

6. Surgical Outcome After Distal Pancreatectomy With and Without Portomesenteric Venous Resection in Patients with Pancreatic Adenocarcinoma: A Transatlantic Evaluation of Patients in North America, Germany, Sweden, and The Netherlands (GAPASURG)

11. Consensus Statement on the Use of Near-Infrared Fluorescence Imaging during Pancreatic Cancer Surgery Based on a Delphi Study: Surgeons’ Perspectives on Current Use and Future Recommendations

12. International differences in the selection and outcome of minimally invasive and open distal pancreatectomy: A transatlantic analysis

13. Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: Pooled analysis of the CAO/ARO/AIO-12 and the OPRA randomized phase 2 trials

14. High CIB1 expression in colorectal cancer liver metastases correlates with worse survival and the replacement histopathological growth pattern

19. Safety and performance of a synthetic sealant patch aimed to prevent postoperative pancreatic fistula after distal pancreatectomy (SHIELDS) – Prospective international multicenter phase II study

22. Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution

31. Clinical outcome after total neoadjuvant treatment (CAO/ARO/AIO-12) versus intensified neoadjuvant and adjuvant treatment (CAO/ARO/AIO-04) a comparison between two multicenter randomized phase II/III trials

34. Prospective randomized multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (ESOPEC trial).

35. Perioperative outcomes in an age-adapted analysis of the German StuDoQ|Pancreas registry for PDAC

41. Arbeitsgruppen zu kolorektalen Tumoren der AIO, der ACO und der ARO – „past, present, and future“

47. MIF/NR3C2 axis regulates glucose metabolism reprogramming in pancreatic cancer through MAPK–ERK and AP-1 pathways.

48. ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic reprogramming in pancreatic cancer.

50. Individualisierte Pankreaschirurgie

Catalog

Books, media, physical & digital resources